A new study led by a Tulane University researcher and recently published in the journal, Lancet Infectious Diseases, could change the way doctors treat the common, sexually transmitted parasite, Trichomonas vaginalis.
Joining me today to talk about trichomoniasis and the new study is the lead author, infectious disease epidemiologist at the Tulane University School of Public Health and Tropical Medicine , Dr. Patricia Kissinger.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Stitcher | RSS
Related:
-
Trichomonas vaginalis
Image/CDC - Trichomonas assay receives FDA clearance for diagnosis of common STD
- Trichomonas vaginalis disproportionately affects the black community: Study
- Infectious disease ‘pearls’, part 2: Outbreak News This Week
- Undocumented immigrants and the import of infectious diseases: A real health security risk to the US?
- Measles, global surveillance and the work of BlueDot
- Antibiotics: Fluoroquinolone prescribing in the US
- What is Capnocytophaga?
- Animal Viruses and Humans: A discussion with author, Dr Warren Andiman
- Pubic Lice: They Don’t Call Them Crabs For Nothing